Functional characterization of EZH2β reveals the increased complexity of EZH2 isoforms involved in the regulation of mammalian gene expression

Epigenetics and Chromatin

Volumn 6, Issue 1, 2013, Pages

  Grzenda, Adrienne ^a   Lomberk, Gwen ^a   Svingen, Phyllis ^a   Mathison, Angela ^a   Calvo, Ezequiel ^b   Iovanna, Juan ^c   Xiong, Yuning ^a   Faubion, William ^a   Urrutia, Raul ^a,c  

^a MAYO CLINIC   (United States)

^b LAVAL UNIVERSITY   (Canada)

^c INSERM   (France)

Author keywords

Chromatin; Enhancer of zeste homologue 2; Epigenetics; EZH2; Histone methyltransferase; Polycomb; Polycomb repressive complex 2; PRC2

Indexed keywords

TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR EZH2 ALPHA; TRANSCRIPTION FACTOR EZH2 BETA; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SILENCING; GENETIC ASSOCIATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

MAMMALIA;

EID: 84874345376     PISSN: None     EISSN: 17568935     Source Type: Journal    
DOI: 10.1186/1756-8935-6-3     Document Type: Article

References (52)

1. The Polycomb complex PRC2 and its mark in life. Margueron R, Reinberg D, Nature 2011 469 343 349 10.1038/nature09784 21248841
2. RYBP-PRC1 complexes mediate H2A ubiquitylation at polycomb target sites independently of PRC2 and H3K27me3. Tavares L, Dimitrova E, Oxley D, Webster J, Poot R, Demmers J, Bezstarosti K, Taylor S, Ura H, Koide H, Wutz A, Vidal M, Elderkin S, Brockdorff N, Cell 2012 148 664 678 10.1016/j.cell.2011.12.029 22325148
3. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y, Science 2002 298 1039 1043 10.1126/science.1076997 12351676 (Pubitemid 35247314)
4. Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Czermin B, Melfi R, McCabe D, Seitz V, Imhof A, Pirrotta V, Cell 2002 111 185 196 10.1016/S0092-8674(02)00975-3 12408863 (Pubitemid 35292439)
5. SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. Cao R, Zhang Y, Mol Cell 2004 15 57 67 10.1016/j.molcel.2004.06.020 15225548 (Pubitemid 38850219)
6. Point mutations in the WD40 domain of Eed block its interaction with Ezh2. Denisenko O, Shnyreva M, Suzuki H, Bomsztyk K, Mol Cell Biol 1998 18 5634 5642 9742080 (Pubitemid 28450514)
7. Structural basis of EZH2 recognition by EED. Han Z, Xing X, Hu M, Zhang Y, Liu P, Chai J, Structure 2007 15 1306 1315 10.1016/j.str.2007.08.007 17937919 (Pubitemid 47539160)
8. Role of the polycomb protein EED in the propagation of repressive histone marks. Margueron R, Justin N, Ohno K, Sharpe ML, Son J, Drury WJ 3rd, Voigt P, Martin SR, Taylor WR, De Marco V, Pirrotta V, Reinberg D, Gamblin SJ, Nature 2009 461 762 767 10.1038/nature08398 19767730
9. The N terminus of Drosophila ESC binds directly to histone H3 and is required for E(Z)-dependent trimethylation of H3 lysine 27. Tie F, Stratton CA, Kurzhals RL, Harte PJ, Mol Cell Biol 2007 27 2014 2026 10.1128/MCB.01822-06 17210640 (Pubitemid 46418460)
10. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Margueron R, Li G, Sarma K, Blais A, Zavadil J, Woodcock CL, Dynlacht BD, Reinberg D, Mol Cell 2008 32 503 518 10.1016/j.molcel.2008.11.004 19026781
11. The Drosophila Polycomb group proteins ESC and E(Z) are present in a complex containing the histone-binding protein p55 and the histone deacetylase RPD3. Tie F, Furuyama T, Prasad-Sinha J, Jane E, Harte PJ, Development 2001 128 275 286 11124122 (Pubitemid 32124152)
12. Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo. Sarma K, Margueron R, Ivanov A, Pirrotta V, Reinberg D, Mol Cell Biol 2008 28 2718 2731 10.1128/MCB.02017-07 18285464 (Pubitemid 351542370)
13. Genome regulation by polycomb and trithorax proteins. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G, Cell 2007 128 735 745 10.1016/j.cell.2007.02.009 17320510 (Pubitemid 46273581)
14. Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3. Kuzmichev A, Jenuwein T, Tempst P, Reinberg D, Mol Cell 2004 14 183 193 10.1016/S1097-2765(04)00185-6 15099518 (Pubitemid 38515646)
15. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Kuzmichev A, Margueron R, Vaquero A, Preissner TS, Scher M, Kirmizis A, Ouyang X, Brockdorff N, Abate-Shen C, Farnham P, Reinberg D, Proc Natl Acad Sci U S A 2005 102 1859 1864 10.1073/pnas. 0409875102 15684044 (Pubitemid 40261977)
16. Polycomb silencers control cell fate, development and cancer. Sparmann A, van Lohuizen M, Nat Rev Cancer 2006 6 846 856 10.1038/nrc1991 17060944 (Pubitemid 44629896)
17. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, Sabel MS, Livant D, Weiss SJ, Rubin MA, Chinnaiyan AM, Proc Natl Acad Sci U S A 2003 100 11606 11611 10.1073/pnas.1933744100 14500907 (Pubitemid 37205983)
18. The polycomb group protein EZH2 is involved in progression of prostate cancer. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM, Nature 2002 419 624 629 10.1038/nature01075 12374981
19. Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer. Bohrer LR, Chen S, Hallstrom TC, Huang H, Endocrinology 2010 151 5136 5145 10.1210/en.2010-0436 20881251
20. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. Bracken AP, Pasini D, Capra M, Prosperini E, Colli E, Helin K, EMBO J 2003 22 5323 5335 10.1093/emboj/cdg542 14532106 (Pubitemid 37279943)
21. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene. Kotake Y, Cao R, Viatour P, Sage J, Zhang Y, Xiong Y, Genes Dev 2007 21 49 54 10.1101/gad.1499407 17210787 (Pubitemid 46089706)
22. Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells. Shi B, Liang J, Yang X, Wang Y, Zhao Y, Wu H, Sun L, Zhang Y, Chen Y, Li R, Zhang Y, Hong M, Shang Y, Mol Cell Biol 2007 27 5105 5119 10.1128/MCB.00162-07 17502350 (Pubitemid 47068285)
23. Activated p53 suppresses the histone methyltransferase EZH2 gene. Tang X, Milyavsky M, Shats I, Erez N, Goldfinger N, Rotter V, Oncogene 2004 23 5759 5769 10.1038/sj.onc.1207706 15208672 (Pubitemid 39093021)
24. Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A. Tonini T, Bagella L, D'Andrilli G, Claudio PP, Giordano A, Oncogene 2004 23 4930 4937 10.1038/sj.onc.1207608 15077161 (Pubitemid 38932165)
25. EZH2 promotes proliferation and invasiveness of prostate cancer cells. Bryant RJ, Cross NA, Eaton CL, Hamdy FC, Cunliffe VT, Prostate 2007 67 547 556 10.1002/pros.20550 17252556 (Pubitemid 46536947)
26. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA, Mehra R, Laxman B, Cao X, Kleer CG, Varambally S, Chinnaiyan AM, Oncogene 2008 27 7274 7284 10.1038/onc.2008.333 18806826
27. Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells. Fujii S, Ochiai A, Cancer Sci 2008 99 738 746 10.1111/j.1349-7006.2008.00743.x 18377425 (Pubitemid 351448078)
28. Regulation of tumor angiogenesis by EZH2. Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L, Armaiz-Pena GN, Hu W, Stone RL, Munkarah A, Ravoori MK, Shahzad MM, Lee JW, Mora E, Langley RR, Carroll AR, Matsuo K, Spannuth WA, Schmandt R, Jennings NB, Goodman BW, Jaffe RB, Nick AM, Kim HS, Guven EO, Chen YH, Li LY, Hsu MC, Coleman RL, Calin GA, Cancer Cell 2010 18 185 197 10.1016/j.ccr.2010.06.016 20708159
29. The Polycomb group protein enhancer of zeste 2: its links to DNA repair and breast cancer. Zeidler M, Kleer CG, J Mol Histol 2006 37 219 223 10.1007/s10735-006-9042-9 16855786 (Pubitemid 44795625)
30. The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells. Zeidler M, Varambally S, Cao Q, Chinnaiyan AM, Ferguson DO, Merajver SD, Kleer CG, Neoplasia 2005 7 1011 1019 10.1593/neo.05472 16331887
31. The Ezh2 methyltransferase complex: actin up in the cytosol. Nolz JC, Gomez TS, Billadeau DD, Trends Cell Biol 2005 15 514 517 10.1016/j.tcb.2005.08. 003 16126384 (Pubitemid 41396431)
32. Polycomb group suppressor of zeste 12 links heterochromatin protein 1alpha and enhancer of zeste 2. Yamamoto K, Sonoda M, Inokuchi J, Shirasawa S, Sasazuki T, J Biol Chem 2004 279 401 406 14570930 (Pubitemid 38044839)
33. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Bracken AP, Dietrich N, Pasini D, Hansen KH, Helin K, Genes Dev 2006 20 1123 1136 10.1101/gad.381706 16618801
34. Polycomb antagonizes p300/CREB-binding protein-associated factor to silence FOXP3 in a Kruppel-like factor-dependent manner. Xiong Y, Khanna S, Grzenda AL, Sarmento OF, Svingen PA, Lomberk GA, Urrutia RA, Faubion WA Jr, J Biol Chem 2012 287 34372 34385 10.1074/jbc.M111.325332 22896699
35. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. Ku M, Koche RP, Rheinbay E, Mendenhall EM, Endoh M, Mikkelsen TS, Presser A, Nusbaum C, Xie X, Chi AS, Adli M, Kasif S, Ptaszek LM, Cowan CA, Lander ES, Koseki H, Bernstein BE, PLoS Genet 2008 4 1000242 10.1371/journal.pgen.1000242 18974828
36. The human EZH2 gene: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders. Cardoso C, Mignon C, Hetet G, Grandchamps B, Fontes M, Colleaux L, Eur J Hum Genet 2000 8 174 180 10.1038/sj.ejhg.5200439 10780782 (Pubitemid 30189860)
37. Interaction of Vav with ENX-1, a putative transcriptional regulator of homeobox gene expression. Hobert O, Jallal B, Ullrich A, Mol Cell Biol 1996 16 3066 3073 8649418 (Pubitemid 26163376)
38. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Shen X, Liu Y, Hsu YJ, Fujiwara Y, Kim J, Mao X, Yuan GC, Orkin SH, Mol Cell 2008 32 491 502 10.1016/j.molcel.2008.10.016 19026780
39. A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G, Reinberg D, Jenuwein T, Genes Dev 2004 18 1251 1262 10.1101/gad.300704 15145825 (Pubitemid 38720593)
40. Evidence for alteration of EZH2, BMI1, and KDM6A and epigenetic reprogramming in human papillomavirus type 16 E6/E7-expressing keratinocytes. Hyland PL, McDade SS, McCloskey R, Dickson GJ, Arthur K, McCance DJ, Patel D, J Virol 2011 85 10999 11006 10.1128/JVI.00160-11 21865393
41. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Su IH, Basavaraj A, Krutchinsky AN, Hobert O, Ullrich A, Chait BT, Tarakhovsky A, Nat Immunol 2003 4 124 131 10.1038/ni876 12496962 (Pubitemid 36193013)
42. Polycomb silencing mechanisms and the management of genomic programmes. Schwartz YB, Pirrotta V, Nat Rev Genet 2007 8 9 22 17173055 (Pubitemid 46006046)
43. Phosphorylation of EZH2 by CDK1 and CDK2: a possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions. Zeng X, Chen S, Huang H, Cell Cycle 2011 10 579 583 21278485
44. Sequence-specific transcriptional repression by KS1, a multiple-zinc-finger-Kruppel-associated box protein. Gebelein B, Urrutia R, Mol Cell Biol 2001 21 928 939 10.1128/MCB.21.3.928-939.2001 11154279 (Pubitemid 32104740)
45. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP, Biostatistics 2003 4 249 264 10.1093/biostatistics/4.2.249 12925520
46. Human Orc2 localizes to centrosomes, centromeres and heterochromatin during chromosome inheritance. Prasanth SG, Prasanth KV, Siddiqui K, Spector DL, Stillman B, EMBO J 2004 23 2651 2663 10.1038/sj.emboj.7600255 15215892 (Pubitemid 38988236)
47. Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. Kondo Y, Shen L, Ahmed S, Boumber Y, Sekido Y, Haddad BR, Issa JP, PLoS One 2008 3 2037 10.1371/journal.pone.0002037 18446223 (Pubitemid 352024760)
48. AffylmGUI: a graphical user interface for linear modeling of single channel microarray data. Wettenhall JM, Simpson KM, Satterley K, Smyth GK, Bioinformatics 2006 22 897 899 10.1093/bioinformatics/btl025 16455752
49. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Murphy KM, Heimberger AB, Loh DY, Science 1990 250 1720 1723 10.1126/science.2125367 2125367 (Pubitemid 120031881)
50. Human coxsackie adenovirus receptor (CAR) expression in transgenic mouse prostate tumors enhances adenoviral delivery of genes. Bao Y, Peng W, Verbitsky A, Chen J, Wu L, Rauen KA, Sawicki JA, Prostate 2005 64 401 407 10.1002/pros.20265 15761871 (Pubitemid 41193253)
51. Sequence-specific recruitment of heterochromatin protein 1 via interaction with Krüppel-like factor 11, a human transcription factor involved in tumor suppression and metabolic diseases. Lomberk G, Mathison AJ, Grzenda A, Seo S, Demars CJ, Rizvi S, Bonilla-Velez J, Calvo E, Fernandez-Zapico ME, Iovanna J, Buttar NS, Urrutia R, J Biol Chem 2012 287 13026 13039 10.1074/jbc.M112.342634 22318730
52. AceView: a comprehensive cDNA-supported gene and transcripts annotation. Thierry-Mieg D, Thierry-Mieg J, Genome Biol 2006 7 Suppl 1 12.11 14